文献速递认知障碍与痴呆帕金森病与运动障碍

阿尔茨海默共病理对路易体痴呆基底前脑萎缩与认知障碍的影响

Alzheimer's Co-Pathology Burden on Basal Forebrain Atrophy and Cognitive Impairment in Dementia with Lewy Bodies: A Cross-Sectional Pilot Study.
PubMed 文献 · Ann Neurol · 2026-09-16

结果显示路易体痴呆患者基底前脑显著萎缩,AD共病理与更重萎缩和皮层变薄相关,基底前脑萎缩介导了pTau/Aβ42比值与神经退行性变的关系。

要点

  • 路易体痴呆患者基底前脑体积较健康对照显著缩小(p<0.001)。
  • AD共病理与更重基底前脑萎缩(p=0.046)和皮层变薄(p=0.025)相关。
  • 基底前脑萎缩介导pTau/Aβ42比值与神经退行性变的关联,并与认知直接相关。

核心结论

  • 路易体痴呆中AD共病理加重基底前脑萎缩,并与认知下降相关。
  • 评估路易体痴呆神经退行性变时需考虑AD共病理。

研究设计与样本

  • 参与者接受神经心理评估、3T MRI和阿尔茨海默生物标志物检测,用体内生物标志物对路易体痴呆患者按AD共病理分组。
  • 用ANCOVA比较基底前脑和海马体积及平均皮层厚度,校正年龄、性别和总颅内体积;用中介分析检验间接效应。

主要发现

  • 路易体痴呆患者基底前脑萎缩显著重于健康对照(p<0.001)。
  • AD共病理与更重基底前脑萎缩(p=0.046)和平均皮层厚度降低(p=0.025)相关。
  • 基底前脑体积与pTau181/Aβ1-42比值相关(p=0.009),与MMSE评分相关(p=0.016)。
  • 中介分析显示基底前脑萎缩介导pTau/Aβ42比值与神经退行性变的关系,且基底前脑与认知障碍直接相关。

临床怎么用

  • 在路易体痴呆评估中应纳入AD共病理生物标志物,以解释基底前脑萎缩和认知下降。
  • 基底前脑体积和pTau/Aβ42比值可作为神经退行性变和认知关联的影像-生物标志物参考。

局限性

  • 单中心研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Dementia with Lewy Bodies (DLB) is the second most common neurodegenerative dementia after Alzheimer's disease (AD), with significant pathological overlap between the two conditions. However, the impact of Alzheimer's co-pathology on basal forebrain (BF) atrophy and its relationship with neurodegeneration and cognitive decline in patients with DLB remains underexplored. METHODS: Forty patients with DLB and 14 healthy controls (HCs) were included from the Centre for Neurodegenerative Diseases, University of Bari. Participants underwent neuropsychological evaluations, 3T magnetic resonance imaging (MRI) scans, and Alzheimer's biomarkers assessment. Patients with DLB were grouped by AD co-pathology using in vivo biomarkers. BF and hippocampal volumes and mean cortical thickness values were analyzed using analysis of covariance (ANCOVA), adjusted for age, sex, and total intracranial volume. Mediation analyses were conducted to examine the indirect effects of Alzheimer's pathology and BF atrophy on neurodegeneration (hippocampal volume and cortical thickness) and cognitive function (Mini-Mental State Examination [MMSE]). RESULTS: Patients with DLB exhibited significant BF atrophy compared with HCs (p < 0.001). AD co-pathology was associated with greater BF atrophy (p = 0.046) and reduced mean cortical thickness (p = 0.025). Significant correlations were found between BF volume and the pTAU181/Aβ1-42 ratio (p = 0.009) and between BF volume and MMSE scores (p = 0.016). Mediation analysis revealed that BF atrophy mediated the relationship between the pTau/Aβ42 ratio and neurodegeneration, and that the BF has a direct association with cognitive impairment. INTERPRETATION: AD co-pathology in DLB exacerbates BF atrophy, correlating with cognitive decline. These results emphasize the need to consider AD co-pathology in evaluating neurodegeneration in DLB, suggesting future studies should explore targeted interventions to address this pathological overlap. ANN NEUROL 2026.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Urso D, Giannelli T, Tafuri B, et al. Alzheimer's Co-Pathology Burden on Basal Forebrain Atrophy and Cognitive Impairment in Dementia with Lewy Bodies: A Cross-Sectional Pilot Study. Ann Neurol. 2026. PMID: 42747246. doi:10.1002/ana.78357

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。